Skip to main content

D. E. Shaw & Co., Inc.

Position in OVID — Ovid Therapeutics Inc.

CIK 1009207 New York, NY

Position in OVID

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$99,199
-$118,156 QoQ
Shares Held
36,877
-48.3% QoQ
Ownership
0.019%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#70
of 130 holders
Holding Since
Dec 2020
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in OVID Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

D. E. Shaw & Co., Inc. holds $5,017,559,982 across 217 Biotechnology names. OVID ranks #199 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in OVID

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $99,199 36,877
2024-03-31 $217,355 71,264
2023-12-31 $252,019 78,267
2023-09-30 $323,742 84,308
2023-06-30 $351,884 107,282
2023-03-31 $875,031 339,160
2022-12-31 $941,767 506,327
2022-09-30 $1,272,033 691,323
2022-06-30 $1,912,132 889,364
2022-03-31 $2,790,520 888,701
2021-12-31 $2,436,697 759,096
2021-09-30 $2,449,204 728,930
2021-06-30 $2,916,527 745,915
2021-03-31 $2,354,534 585,705
2020-12-31 $490,627 212,393